PREFORMULATION STUDY OF PIROXICAMAbstract
Preformulation testing is the first step in the rational development of dosage forms of a drug substance. The preformulation investigations confirm that there are no significant barriers to the compound’s development as a marketed drug. The formulation scientist uses this information to develop an efficacious, stable and safe dosage form. The main objective of the present research work was to do preformulation study of piroxicam drug. Piroxicam (PC) is one of the most potent non-steroidal anti-inflammatory agents that also has anti-pyretic activity and has been used for the treatment of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, tendinitis, bursitis, and for the pain that is not related to a musculoskeletal system and traumatic contusions. The Principal advantage of piroxicam is its long half-life, which permits the administration of a single daily dose. As the piroxicam is very effective drug, many researchers use this drug in their research. This research paper helps those people who want to use piroxicam drug for their research.
A. A. Bachhav *, S. A. Ahire and A. G. Jadhav
Department of Pharmaceutics, Sandip Institute of Pharmaceutical Sciences, Nashik, Maharashtra, India.
14 June 2018
05 August 2018
07 August 2018
01 February, 2019